{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"1","upperLimit":"18","value":"9.5"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"2"}],"units":"Participants"}],"dispersionType":"Full Range","groups":[{"description":"Pomalidomide, 4 mg by mouth daily on days 1-21 of 28 day cycle Dexamethasone, 40 mg by mouth on days 1, 8, 15, and 22 of 28 day cycle Romidepsin, IV on days 1 and 15 of 28 day cycle, dose level to be determined","id":"OG000","title":"ALL Patients"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"From start of treatment, to date of disease progression (on average, ten 28-day cycles)","title":"Time to Disease Progression (Progression Free Survival)","type":"SECONDARY","unitOfMeasure":"cycles (defined as 28 days)"}